Hormone replacement therapy and the bladder

Journal of the British Menopause Society

Volumn 10, Issue 1, 2004, Pages 30-32

  McCully, Keri S ^a   Jackson, Simon ^b  

^a MILTON KEYNES GENERAL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Bladder; Hormone replacement therapy; Oestrogen; Urinary incontinence; Urinary tract infections

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRIOL; ESTROGEN DERIVATIVE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

AGING; BREAST TENDERNESS; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ESTROGEN DEFICIENCY; EVIDENCE BASED MEDICINE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MICTURITION; POSTMENOPAUSE; RECURRENT INFECTION; REVIEW; RISK REDUCTION; STRESS INCONTINENCE; URGE INCONTINENCE; URINARY FREQUENCY; URINARY TRACT DISEASE; URINARY TRACT INFECTION; URINE INCONTINENCE; VAGINA BLEEDING; VAGINA RING;

EPIDEMIOLOGIC STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; URINARY INCONTINENCE; URINARY TRACT INFECTIONS;

EID: 1942439131     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218004322986753     Document Type: Review

References (44)

1. Barlow DH, Cardozo LD, Francis RM, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997; 104: 87-91.
2. Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. BMJ 1980; 281: 1243-1245.
3. Foxman B, Barlow R, D'Arcy H, et al. Urinary tract infections: Self-reported incidence and associated costs. Ann Epidemiol 2000; 10: 509-515.
4. Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994; 83: 12-18.
5. Saez S, Martin PM. Evidence of estrogen receptors in the trigone area of human urinary bladder. J Steroid Biochem 1981; 15: 317-20.
6. Iosif CS, Batra S, Ek A, et al. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 1981; 141: 817-820.
7. Zuckerman S. Morphologic and functional homologies of the male and female reproductive system. Br Med J 1936; 2: 864-865.
8. Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 2000; 86: 32-38.
9. Salmon UJ, Walker RI, Geist SH. The use of estrogen in the treatment of dysuria and incontinence in postmenopausal women. Am J Obstet Gynecol 1941; 42: 845-847.
10. Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. (Cochrane review.) Cochrane Database of systematic reviews (2);CD 001405,2003.
11. Benness C, Gangar K, Cardozo LD, Cutner A, Whitehead M. Do progestogens exacerbate incontinence in women on HRT? Neurourol Urodyn 1991; 10: 316-318.
12. Fantl JA, Wyman JF, McClish DK, Bump RC. Urinary incontinence in community-dwelling women:Clinical, urodynamic and severity characteristics. Am J Obstet Gynecol 1990; 162: 946-951.
13. Robinson D, Cardozo L. Risk factors for urinary incontinence in women. J Br Menopause Soc 2003; 9: 75-79.
14. Tsai E, Yang C, Chen H, et al. Bladder neck circulation by Doppler ultrasonography in postmenopausal women with urinary stress incontinence. Obstet Gynecol 2001; 98: 52-56.
15. Klutke JJ, Bergman A. Hormonal influence on the urinary tract. Urol Clin North Am 1995; 22: 629-639.
16. Benness C J, Wise B G, Cutner A, Cardozo L. Does low dose vaginal estradiol improve freguency and urgency in postmenopausal women? In: American Urogynecology Society 13th annual meeting, Sept 27-30 1992. Cambridge, Massachussetts, USA, 1992: 281.
17. Blom M, Sommers B. The effects of an estradiol transdermal therapeutic system, alone and in combination with naproxen, on urge incontinence in the elderly women: a pilot study. Curr Ther Res Clin Exp 1995; 56: 1100-1104.
18. Cardozo L, Rekers H, Tapp A, et al. Oestriol in the treatment of postmenopausal urgency: a multicentre study. Maturitas 1993; 18: 47-53.
19. Henalla S M, Hutchins C J, Robinson P, MacVicar J. Non-operative methods in the treatment of female genuine stress incontinence of urine. J Obstet Gynaecol 1989; 9: 222-225.
20. Henalla S M, Millar D R, Wallace K J. Surgical versus conservative management for post-menopausal genuine stress incontinence of urine (abstract). Neurourol Urodyn 1990; 9: 436-437.
21. Hilton P, Tweddell A L, Mayne C. Oral and intravaginal estrogens alone and in combination with alph-adrenergic stimulation in genuine stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1990; 1: 80-86.
22. Jackson S, Shepard A, Brookes S, Abrahams P. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol 1999; 106: 711-718.
23. Judge TG. The use of quinestradol in the elderly incontinent women, a preliminary report. Gerontol Clin (Basel) 1969; 11: 159-164.
24. Enzelsberger H, Kurz C, Schatten C, Huber J. Zur wirksamkeit einer intravaginalen oestriol tabletten applikation bei frauen mit urge-inkontinenz (Effects of intravaginal application of oestriol tablets in women with urge incontinence). Geburtshilfe Frauenheilkd 1991; 51: 834-838.
25. Kurz C, Nagele F, Sevelda P, Enzelberger H. Intravesikal appliziertes oestriol bei sensorischer urge-inkontinenz - eine prospektive studie (Intravesical application of estriol in sensory urge incontinence - a prospective study). Geburtshilfe Frauenheilkd 1993; 53: 535-538.
26. Rufford J, Hextall A, Cardozo L, Khullar V. A double blind placebo controlled trial on the effects of 25mg oestradiol implants on the urge syndrome in the postmenopausal women (personal communication). Due for submission.
27. Sacco F, Rigon G, Carbone A, Sacchini D. Terapia estrogenica trasvaginale dell'incontinenza urinaria da sforzo (Transvaginal estrogen therapy for stress incontinence). Minerva Ginecol 1990; 42: 539-544.
28. Samsioe G, Jansson I, Mellstroem D, Svanborg A. Occurence, nature and treatment of incontinence in a 70-year-old female population. Maturitas 1985; 7: 335-342.
29. Walter S, Wolf Ç, Âarlebo Ç, Jensen C.E. Urinary incontinence in postmenopausal women treated with oestrogen. A double-blind clinical trial. Urol Int 1978; 33: 135-143.
30. Wilson PD, Faragher B, Butler B, et al. Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women. Br J Obstet Gynaecol 1987; 94: 568-574.
31. Ouslander JG, Greendale GA, Uman G, et al. Effects of oral estrogen and progestin on the lower urinary tract among female nursing home residents. J Am Geriatr Soc 2001; 49: 803-807.
32. Grady D, Brown J S, Vittinghoff E, et al. Postmenopausal hormones and incontinence: the heart and estrogen/progestin replacement study. Obstet Gynecol 2001; 97: 116-120.
33. Fantl JA, Richard C, Bump C, et al. Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group. Obstet Gynecol 1996; 88: 745-749.
34. Rud T. The effects of estrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women. Acta Obstet Gynecol Scand 1980; 59: 265-270.
35. Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. Br J Obstet Gynaecol 2000; 107: 1029-1034.
36. Chompootaweep S, Nunthapisud P, Trivijitslip P, et al. The use of two estrogen preparations (a combination contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study. Clinl Pharmacol Ther 1998; 64: 204-210.
37. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999; 180: 1072-1079.
38. Enzelsberger H, Schatten C, Kurz C, Zorzi P. Zur Behandlung der weiblichen Urge-Inkontinenz durch lokale Oestrogentherapie (Treatment of female urge incontinence by local estrogen therapy). Gynakol Rundsch 1990; 30 (Suppl 1): 235-236.
39. Brown J S, Vittinghoff E, Kanaya AM, et al; Heart and Estrogen/Progestin Replacement Study Research Group. Urinary tract infections in postmenopausal women: Effect of hormone therapy and risk factors. Obstet Gynecol 2001; 98: 1045-1052.
40. Raz R, Genniesin Y, Wasser J, et al. Recurrent urinary tract infections in post menopausal women. Clin Infect Dis 2000; 30: 152-156.
41. Raz R, Stamm WE. A controlled trial of intravaginal estriol in the postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753-757.
42. Fantl J A, Wyman J R, Anderson R L, et al. Post menopausal urinary incontinence: Comparison between non-estrogen-supplemented and estrogen-supplemented women. Obstet Gynecol 1988; 71: 823-828.
43. Cardozo L, Benness C, Abbott D. Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol 1998; 105: 403-407.
44. Dwyer P L, O'Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynaecol 2002; 14: 537-543.